NMFC vs PRAA

NMFC exhibits significant financial instability characterized by a mediocre Piotroski F-Score of 4/9 and a technical trend of 0/100. While the stock trades at a discount to book value (P/B 0.71), it is priced well above its Graham Number ($6.44) and intrinsic value ($1.12). The most alarming metric is the 800% dividend payout ratio, which suggests the current 15.57% yield is unsustainable based on GAAP earnings. Negative revenue growth and a consistent track record of earnings misses further degrade the outlook.

PRAA presents a stark contrast between deep value metrics and severe fundamental deterioration, highlighted by a critical Piotroski F-Score of 1/9. While the stock trades at a discount to book value (P/B 0.83) and shows strong recent price momentum (+55.9% in 6 months), the underlying financial health is weak with a high Debt/Equity ratio of 3.60. The company is experiencing extreme earnings volatility, evidenced by a massive -2893.8% surprise in late 2025, though recent quarterly growth suggests a potential turnaround. Overall, the valuation is attractive, but the deterministic health scores signal high risk.